2.7.1.105	(2E)-1-(pyridin-4-yl)-3-(quinolin-2-yl)prop-2-en-1-one	-	213172	
2.7.1.105	(2E)-3-(pyridin-3-yl)-1-(pyridin-4-yl)prop-2-en-1-one	-	213171	
2.7.1.105	1-(3-pyridinyl)-3-(2-quinolinyl)-2-propen-1-one	-	232532	
2.7.1.105	1-(4-pyridinyl)-3-(2-quinolinyl)-2-propen-1-one	the inhibitor causes a rapid induction of apoptosis in transformed cells, has adequate pharmacokinetic properties, suppresses the glucose uptake and growth of Lewis lung carcinomas in syngeneic mice and yields anti-tumor effects in three human xenograft models of cancer in athymic mice that are comparable to FDA-approved chemotherapeutic agents	213169	
2.7.1.105	1-(4-pyridinyl)-3-(2-quinolinyl)-2-propen-1-one	-	213169	
2.7.1.105	2,5-anhydro-D-mannitol 6-phosphate	-	19904	
2.7.1.105	2-((5-bromo-6-oxo-1-phenyl-1,6-dihydropyridazin-4-yl)amino)acetamide	-	197128	
2.7.1.105	2-(2-bromoacetamido)ethyl phosphate	an irreversible inhibitor of PFK-2 in several cancer cell lines	213170	
2.7.1.105	2-(5-bromo-6-oxo-1-phenyl-1,6-dihydropyridazin-4-yl)-1,2,3,4-tetrahydroisoquinoline-5-carbonitrile	-	197126	
2.7.1.105	2-hydroxy-4-[(naphthalen-1-ylsulfonyl)amino]benzoic acid	-	213174